Follow the CMG제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, CMG제약 has logged 5 reports. Market capitalisation: €165.9bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: CMG제약. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.